معرفی
Dr. Xiaoyong Yang is a Professor of Comparative Medicine (primary) and Cellular and Molecular Physiology (secondary) at Yale School of Medicine. He holds an adjunct professorship at Johns Hopkins University and founded Yale's Cancer Metabolism Initiative (CAMI). His education includes a B.S. from Nankai University, M.S. from Peking University, Ph.D. from the University of Alabama at Birmingham, and postdoctoral training at The Salk Institute under Dr. Ronald Evans.
His research investigates metabolic regulation through protein modifications (O-GlcNAc) and circadian rhythms, targeting diseases like diabetes, obesity, and cancer. Key areas include:
- Nutrient-sensing via O-GlcNAc and its impact on signal transduction
- Molecular links between circadian clocks and metabolic physiology
- Nuclear receptors as integrators of metabolic and circadian cues
Publication analysis (2013-2025) reveals consistent focus on O-GlcNAc signaling in metabolic disorders, with recent advances in liver disease mechanisms, obesity regulation, and optogenetic tools for cellular control.
Awards include:
- Elected Member, Connecticut Academy of Science and Engineering (2024)
- Presidential Service Excellence Award, SAPA (2023)
- Innovative Basic Science Award, American Diabetes Association (2019)
Dr. Yang actively mentors trainees and leads a research group exploring metabolic physiology, though no formal lab name is specified. He seeks graduate students and postdocs for projects combining cutting-edge techniques to address metabolic disease challenges.
